COMMENTARY

Treating Menopause: Are We Going Loco?

Charles P. Vega, MD

August 06, 2013

Best Evidence Review of Recommendations on Hormone Therapy

The Study

Panay N, Hamoda H, Arya R, et al. The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy. Menopause Int. 2013;19:59-68.

Introduction

Results from the Women's Health Initiative (WHI) trial changed the indications and even the name of hormone therapy, which led to a severe pullback in the treatment of menopausal symptoms. Reflection on the limitations of the WHI and results from newer research suggest that hormone therapy is safer than previously believed for symptomatic treatment, but new recommendations from the British Menopause Society and Women's Health Concern once again address hormone therapy as a preventive intervention. Meanwhile, a new form of paroxetine has been approved by the US Food and Drug Administration to treat hot flashes, but what role should nonhormonal therapy play in the management of menopausal symptoms?

1 2 3 4 5

Next Section

Cite this: Treating Menopause: Are We Going Loco? - Medscape - Aug 06, 2013.

Best Evidence Review of Recommendations on HRT
Background to the Study
The New Recommendations on Hormone Therapy
Nonhormonal Agent for Vasomotor Symptoms of Menopause
Clinical Pearls
References

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.